Business
New commercialisation partner in Asia Pacific
New commercialisation partner in Asia Pacific.
About this update from Probiotix Health Plc
[{"type":"text","content":"\n \n \n \n ProBiotix Health plc\n \n \n \n \n (\"ProBiotix\" or the \"Company\")\n \n \n \n \n \n \n \n \n \n New commercialisation partner in Asia Pacific\n \n \n \n \n \n \n \n \n ProBiotix Health plc (AQSE: PBX), a life sciences company developing clinically proven probiotic solutions to tackle chronic lifestyle diseases like high cholesterol, high blood pressure and atherosclerosis, announces the appointment of Nutraconnect Pte Ltd (\"Nutraconnect\") to\n develop and implement go-to-market strategies for\n LPLDL®\n as an ingredient, and CholBiome® products, in the Asia Pacific\n (\"APAC\")\n region.\n \n \n \n \n \n Nutraconnect is a nutraceutical business growth acceleration service headquartered in Singapore. The company provides end-to-end solutions for global nutraceutical companies that are looking to establish a foundation for sustainable growth in the fragmented, but vibrant\n APAC\n market. Nutraconnect possesses an established network of industry contacts and a wealth of experience in successfully bringing innovative and science backed ingredients and products to markets in the region.\n \n \n \n \n \n \n Stephen O'Hara,\n \n \n C\n \n EO of ProBiotix Health plc, commented\n : \"Nutraconnect brings extensive industry expertise and a network of high-level contacts in the APAC region, combined with an extensive distribution and agency network. This agreement will help expedite the commercialisation of\n \n LPLDL®\n \n \n and CholBiome\n \n ®\n \n in important countries in the region, whilst allowing ProBiotix to focus internal resources on developing new opportunities in dairy and building a presence in the North American market.\"\n \n \n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n \n \n \n \n \n \n \n \n ProBiotix Health plc\n \n \n \n \n \n \n https://probiotixhealth-ir.com/\n \n \n \n \n \n \n \n Stephen O'Hara, Chief Executive Officer\n \n \n \n \n \n Contact via Walbrook below\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Peterhouse Capital Ltd (AQSE Corporate Adviser and Broker)\n \n \n \n \n \n Tel: 020 7220 0500\n \n \n \n \n \n \n Mark Anwyl\n \n \n \n \n Tel: 020 7469 0930\n \n \n \n \n \n \n Duncan Vasey\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR Ltd\n \...